Showing results (61-70 of 3,094) with videos related to
Sort By:
Pageof 310
Expert Review of Anticancer Therapy|June 6, 2017
Regorafenib for the treatment of unresectable hepatocellular carcinomaLorenza Rimassa, Tiziana Pressiani, Nicola Personeni, et al.Expert Review of Anticancer Therapy|June 27, 2017
Neratinib for the treatment of HER2-positive early stage breast cancerIsabel Echavarria, Sara López-Tarruella, Iván Márquez-Rodas, et al.Expert Review of Anticancer Therapy|June 27, 2017
The safety and efficacy of palbociclib in the treatment of metastatic breast cancerJohannes Ettl, Nadia HarbeckExpert Review of Anticancer Therapy|February 2, 2022
Naltrexone at low doses (LDN) and its relevance to cancer therapyWai M Liu, Angus G DalgleishExpert Review of Anticancer Therapy|May 5, 2022
The use of real-world evidence to support FDA post-approval study requirements for oncology drugsMarjorie E ZettlerExpert Review of Anticancer Therapy|July 15, 2022
Clinically-meaningful improvements in therapy for unresectable NSCLCSeigo Katakura, Shuji MurakamiExpert Review of Anticancer Therapy|July 14, 2022
Efficacy and safety of multi-kinase inhibitors in patients with radioiodine-refractory differentiated thyroid cancer: a systematic review and meta-analysis of clinical trialsJingyang Su, Menglei Wang, Yue Fu, et al.Expert Review of Anticancer Therapy|April 28, 2022
Adjuvant therapy for patients with renal cell carcinoma following surgery: a focus on pembrolizumabMichael Serzan, Michael B AtkinsExpert Review of Anticancer Therapy|February 17, 2022
Cemiplimab for locally advanced and metastatic basal cell carcinomaThomas Damsin, Eve Lebas, Nathalie Marchal, et al.Expert Review of Anticancer Therapy|May 17, 2018
A look at treatment strategies for relapsed multiple myelomaGiusy Cetani, Mario Boccadoro, Stefania OlivaPageof 310